SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (362)10/29/2000 9:49:29 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 1833
 
In this week's BioCentury, it's indicated that Kyowa Hakko has an adenosine A2R antagonist in phase II trials for depression.